215 related articles for article (PubMed ID: 23534727)
1. Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.
Li SL; Su M; Peng T; Xiao KY; Shang LM; Xu BH; Su ZX; Ye XP; Peng N; Qin QL; Chen DF; Chen J; Li LQ
Asian Pac J Cancer Prev; 2013; 14(1):217-23. PubMed ID: 23534727
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
Hepatogastroenterology; 2015; 62(138):399-404. PubMed ID: 25916071
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
[TBL] [Abstract][Full Text] [Related]
4. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.
Li Q; Wang J; Juzi JT; Sun Y; Zheng H; Cui Y; Li H; Hao X
J Gastrointest Surg; 2008 Sep; 12(9):1540-7. PubMed ID: 18629593
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis.
Shimada M; Hamatsu T; Yamashita Y; Rikimaru T; Taguchi K; Utsunomiya T; Shirabe K; Sugimachi K
World J Surg; 2001 Aug; 25(8):991-5. PubMed ID: 11571981
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
8. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
9. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
[TBL] [Abstract][Full Text] [Related]
10. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
[TBL] [Abstract][Full Text] [Related]
11. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
[TBL] [Abstract][Full Text] [Related]
14. Long-term oncologic results of anatomic vs. parenchyma-sparing resection for hepatocellular carcinoma. A propensity score-matching analysis.
Famularo S; Di Sandro S; Giani A; Lauterio A; Sandini M; De Carlis R; Buscemi V; Romano F; Gianotti L; De Carlis L
Eur J Surg Oncol; 2018 Oct; 44(10):1580-1587. PubMed ID: 29861336
[TBL] [Abstract][Full Text] [Related]
15. [Comparative proteomic approach in differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinomas].
Su M; Li LQ; Peng T; Guo Y; Xiao KY; Shang LM; Xu BH; Li SL; Su ZX; Ye XP
Chin J Cancer; 2010 Jan; 29(1):52-8. PubMed ID: 20038311
[TBL] [Abstract][Full Text] [Related]
16. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis.
Yasui M; Harada A; Nonami T; Takeuchi Y; Taniguchi K; Nakao A; Takagi H
World J Surg; 1997 Oct; 21(8):860-4; discussion 864-5. PubMed ID: 9327679
[TBL] [Abstract][Full Text] [Related]
17. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors.
Furuta M; Ueno M; Fujimoto A; Hayami S; Yasukawa S; Kojima F; Arihiro K; Kawakami Y; Wardell CP; Shiraishi Y; Tanaka H; Nakano K; Maejima K; Sasaki-Oku A; Tokunaga N; Boroevich KA; Abe T; Aikata H; Ohdan H; Gotoh K; Kubo M; Tsunoda T; Miyano S; Chayama K; Yamaue H; Nakagawa H
J Hepatol; 2017 Feb; 66(2):363-373. PubMed ID: 27742377
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
[TBL] [Abstract][Full Text] [Related]
19. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
[TBL] [Abstract][Full Text] [Related]
20. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.
Hao S; Fan P; Chen S; Tu C; Wan C
J Gastrointest Surg; 2017 Feb; 21(2):312-320. PubMed ID: 27815759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
